Table 1 Association of RBM3 IHC results and clinico-pathological features of esophageal adenocarcinoma samples

All cancers

268

33.58

66.42

 < 65 years

84

65.76

34.24

0.7355

 > 65 years

184

67.86

32.14

 male

226

33.63

66.37

0.9703

 female

42

33.33

66.67

 pT1

55

23.64

76.36

0.333

 pT2

28

35.71

64.29

 pT3

163

36.81

63.19

 pT4

20

35

65

 I

52

19.23

80.77

0.0031

 II

36

30.56

69.44

 III

155

34.84

65.16

 IV

24

62.5

37.5

 G1

14

21.43

78.57

0.6477

 G2

98

35.71

64.29

 G3

150

33.33

66.67

 G4

4

50

50

 R0

193

34.72

65.28

0.4129

 R1

69

30.43

69.57

 R2

3

66.67

33.33

 N0

82

24.39

75.61

0.1623

 N1

43

34.88

65.12

 N2

65

41.54

58.46

 N3

75

34.67

65.33

 M0

244

30.74

69.26

0.0024

 M1

24

62.5

37.5